HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

insulin glulisine

provides greater beta-cell protective action
Also Known As:
B3-lysyl-B29-glutamylinsulin; insulin, Lys(B3)-Glu(B29)-; insulin, lysyl(B3)-glutamyl(B29)-
Networked: 28 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Moral, M A: 3 articles (12/2010 - 11/2009)
2. Tomillero, A: 3 articles (12/2010 - 11/2009)
3. Kawamori, R: 2 articles (09/2009 - 09/2009)
4. Iwamoto, Y: 2 articles (09/2009 - 09/2009)
5. Iwasaki, M: 2 articles (09/2009 - 09/2009)
6. Kadowaki, T: 2 articles (09/2009 - 09/2009)
7. Taxis, Katja: 1 article (06/2015)
8. Berhe, Derbew Fikadu: 1 article (06/2015)
9. Haaijer-Ruskamp, Flora M: 1 article (06/2015)
10. Juhlin, Kristina: 1 article (06/2015)

Related Diseases

1. Type 2 Diabetes Mellitus (MODY)
2. Diabetes Mellitus
3. Hyperglycemia
4. Weight Gain
5. Hypoglycemia (Reactive Hypoglycemia)
11/01/2011 - "Insulin glulisine may ameliorate nocturnal hypoglycemia related to insulin antibody--a case report."
01/01/2009 - "The frequency of hypoglycemia, convenience in the timing of administration, and improvements in terms of HbA(1c) seem similar among the rapid-acting insulin analogs, including insulin glulisine. "
07/01/2005 - "Insulin glulisine effectively controls postprandial glucose excursions in both type 1 and type 2 diabetic patients without increasing the risk of hypoglycemia. "
01/01/2015 - "This noninterventional, 8-month, prospective, multicenter study evaluated parameters of glucose control, occurrence of adverse events (eg, hypoglycemia), and acceptance of devices in daily clinical practice routine after 12 and 24 weeks of intensifying insulin therapy to a BBT regimen starting from either preexisting BOT with insulin glargine (pre-BOT) or preexisting SIT with ≥3 daily injections of insulin glulisine (pre-SIT). "
07/01/2012 - "Search terms included "animal insulin," "synthetic insulin," "regular human insulin," "insulin lispro," "insulin aspart," "insulin glulisine," "insulin glargine," "insulin detemir," "insulin degludec," "biphasic human insulin," "insulin premixes," "ultra-long acting," "oral insulin," and "inhaled insulin." While the discovery of animal insulin significantly decreased mortality rates from diabetes, issues with availability and large variability between batches led to difficulty in determining proper doses and, subsequently, challenges in achieving glycemic control and avoiding hypoglycemia. "

Related Drugs and Biologics

1. Hypoglycemic Agents (Hypoglycemics)
2. Insulin (Novolin)
3. glargine (insulin glargine)
4. basal insulin
5. insulin LISPRO (Humalog)
6. Glucose (Dextrose)
7. Ribavirin (Virazole)
8. Potassium
9. Blood Glucose (Blood Sugar)
10. MK 0518

Related Therapies and Procedures

1. Stents
2. Injections
3. Drug-Eluting Stents